Therapy Areas: Inflammatory Diseases
19 November 2019 - - The United States Food and Drug Administration has approved US-based pharmaceutical company Pfizer Inc.'s (NYSE: PFE) Abrilada (adalimumab-afzb), as a biosimilar to Humira&nb...
18 November 2019 - Healthcare company Novartis revealed on Friday the receipt of approval from the US Food and Drug Administration (FDA) for Adakveo to reduce the frequency of vaso-occlusive crises (V...
18 November 2019 - 3SBio Inc (HKEX:1530), a biotechnology company in China, has signed a collaboration agreement with United States-based Verseau Therapeutics Incorporated for VTX-0811, a monoclonal a...
15 November 2019 - - UK-based immune-mediated inflammatory disease specialist PredictImmune has named James Clark as chief technology officer, the company said.
Previously CEO of EnteroBiotix, s...
15 November 2019 - United States-based Finch Therapeutics Group Inc has expanded its collaboration with Japan-based Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK).It was reported yesterday ...
13 November 2019 - - US-based biotechnology company Magenta Therapeutics (NASDAQ: MGTA) has presented new data showing successful immune reset with a single dose of its CD45-ADC in models of three aut...
Related Headlines